David Brayden is a pharmacologist and a Full Professor (Advanced Drug Delivery) at the School of Veterinary Medicine, University College Dublin (UCD), Ireland, and also a Fellow of the UCD Conway Institute. Following 10 years as a researcher in Elan Corporation, he joined UCD in 2001 and was appointed Full Professor in 2014. His main research interests are in oral delivery of peptides using permeation enhancers and nanoparticle technology. He was Director of the Science Foundation Ireland (SFI) Drug Delivery Research Network from 2007-2013, is Deputy Coordinator of an FP7 Consortium on oral peptides in nanoparticles (“TRANS-INT”, 2012-2017), and is a Co-PI in “CURAM”, SFI’s Centre for Medical Devices (2014-2020). He is the author or co-author of more than 200 research publications and patents and was made a Fellow of the Controlled Release Society in 2012. Professor Brayden serves on the Editorial Advisory Boards of Drug Discovery Today, European Journal of Pharmaceutical Sciences, and Advanced Drug Delivery Reviews and is an Associate Editor of Therapeutic Delivery.